L04AC18 Rizankizumab
ATC class of level 5 – chemical substance
This page lists the patient medication information or the product monograph for 2 drugs in this drug class.
- 2 prescription (Rx)
Active ingredient: Risankizumab – all drugs with this active ingredient, also in combination.
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,167 drugs
- L04 Immunosuppressants 279 drugs
- L04A Immunosuppressants 279 drugs
- L04AC Interleukin inhibitors 34 drugs
- L04AC18 Rizankizumab 2 drugs
- L04AC Interleukin inhibitors 34 drugs
- L04A Immunosuppressants 279 drugs
- L04 Immunosuppressants 279 drugs
Drugs in the class
| Drug | Rx or OTC |
|---|---|
| Skyrizi (Abbvie, 150 mg, ..., 55 mg) PM | prescription (Rx) |
| Skyrizi (Abbvie, 75 mg) PM | prescription (Rx) |
Other classes of the same level
- L04AC01 Daclizumab 3 drugs
- L04AC02 Basiliximab 1 drug
- L04AC03 Anakinra 1 drug
- L04AC05 Ustekinumab 9 drugs
- L04AC07 Tocilizumab 3 drugs
- L04AC08 Canakinumab 2 drugs
- L04AC10 Secukinumab 1 drug
- L04AC11 Siltuximab 1 drug
- L04AC12 Brodalumab 1 drug
- L04AC13 Ixekizumab 1 drug
- L04AC14 Sarilumab 2 drugs
- L04AC16 Guselkumab 1 drug
- L04AC17 Tildrakizumab 1 drug
- L04AC19 Satralizumab 1 drug
- L04AC21 Bimekizumab 1 drug
- L04AC22 Spesolimab 1 drug
- L04AC24 Mirikizumab 2 drugs
Other names of the drug class
- English (United Kingdom): L04AC18 risankizumab
- German: L04AC18 Risankizumab
- Spanish: L04AC18 Risankizumab
- German (Austria): L04AC18 Risankizumab
- Italian: L04AC18 Risankizumab
- Turkish: L04AC18 risankizumab
- German (Switzerland): L04AC18 Risankizumab
- French (Switzerland): L04AC18 Risankizumab
- Italian (Switzerland): L04AC18 Risankizumab
- Slovak: L04AC18 Rizankizumab
- Polish: L04AC18 Ryzankizumab
- Dutch: L04AC18 Risankizumab
- Czech: L04AC18 Risankizumab
- French (Canada): L04AC18 Risankizumab
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L04AC18
Ask your doctor or pharmacist for advice.